21 results
424B5
ABOS
Acumen Pharmaceuticals Inc
20 Jul 23
Prospectus supplement for primary offering
4:11pm
to their needs, objectives and circumstances, and, if necessary, seek expert advice on those matters.
Notice to Prospective Investors in Hong Kong
424B5
ABOS
Acumen Pharmaceuticals Inc
17 Jul 23
Prospectus supplement for primary offering
4:49pm
to their needs, objectives and circumstances, and, if necessary, seek expert advice on those matters.
Notice to Prospective Investors in Hong Kong
The shares
424B5
0zjyo crlxi995r41kr
27 Apr 23
Prospectus supplement for primary offering
7:06am
PRE 14A
vdnqivmd wnym6pr7jz7
14 Apr 23
Preliminary proxy
4:33pm
S-3
krjr bsdx
1 Jul 22
Shelf registration
5:06pm
DEF 14A
0vqmfz k0nf8d
27 Apr 22
Definitive proxy
5:03pm
10-K
lrdow49z
28 Mar 22
Annual report
4:51pm
10-Q
lnept vj8ld0i
16 Aug 21
Quarterly report
4:51pm
424B4
ztcgrb4v1hrgbmr8
2 Jul 21
Prospectus supplement with pricing info
4:09pm
S-1/A
EX-10.1
ziobgjm68i5
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
EX-10.6
shfikcy
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
z1yzkh87
24 Jun 21
IPO registration (amended)
8:17am
S-1
EX-10.1
rkg9mn3jr
9 Jun 21
IPO registration
5:02pm
S-1
42q8 3fw4x5xhrq
9 Jun 21
IPO registration
5:02pm
DRS/A
EX-10.1
610bf
3 Jun 21
Draft registration statement (amended)
12:00am
DRS/A
56pok2hw8t00
14 May 21
Draft registration statement (amended)
12:00am